page-loading-spinner
Home Germany Sinking, Election Fraud, and Tariffs for Dummies
Economy
Geopolitics
Scouting Report

Germany Sinking, Election Fraud, and Tariffs for Dummies

Chris discusses Germany’s economic and political challenges, including paper shortages, electricity prices, tariffs, election integrity, and pharmaceutical research corruption, emphasizing the need for reform and accountability.

The User's Profile Chris Martenson November 12, 2024
36
placeholder image

Executive Summary

Chris discusses the current economic and political challenges facing Germany, including a paper shortage affecting elections, soaring electricity prices, and financial stress indicated by the German swap spread. He also critiques the impact of tariffs on consumer prices and highlights issues of election integrity and corruption in pharmaceutical research. Chris emphasizes the need for reform and accountability in these areas.

Germany’s Economic Challenges

Germany is experiencing significant economic challenges, including a paper shortage that may impact elections and soaring electricity prices due to low renewable energy production. This has led to increased electricity imports and financial stress, as indicated by the collapse of the German swap spread. Additionally, funds diverted to support Ukraine have resulted in cuts to domestic investments, such as schools and railroads.

Tariffs and Consumer Impact

Chris explains how tariffs, such as those imposed by Trump, can lead to increased consumer prices. He argues that tariffs often result in companies seeking alternative suppliers or potentially bringing manufacturing back to the United States, rather than simply passing costs onto consumers.

Election Integrity Concerns

Chris raises concerns about election integrity, suggesting that there have been attempts to manipulate election outcomes. He advocates for the appointment of an election czar to ensure fair and transparent electoral processes.

Corruption in Pharmaceutical Research

Chris highlights corruption in pharmaceutical research, noting that the industry paid $1.06 billion to reviewers at top medical journals between 2020 and 2022.

Preview the Video

The rest is exclusive content for members

Curious about what being a member offers? Sign up now for a risk-free trial and get a sneak peek into the premium content, features, and perks awaiting you on the other side.

Community

Top Comment

In the video they show evidence that the FDA purposely delayed the approval of the jabs for the 2020 election and then immediately after it...
Anonymous Author by westcoastjan
13
Image | Hard Assets Alliance

Hard Assets Alliance

Learn more
Image | Peak Prosperity Community

Peak Prosperity Community

Learn more